
Is sotagliflozin better than dapagliflozin?
As a curious investor in the field of pharmaceuticals, I'm wondering if you could offer your professional opinion on the debate surrounding sotagliflozin and dapagliflozin. Both drugs have been making waves in the diabetes treatment space, but which one truly stands out as the superior option? What factors should we consider when evaluating their effectiveness, safety, and potential market impact? I'm eager to gain a deeper understanding of the pros and cons of each medication, as well as any insights you may have on the future trajectory of these groundbreaking treatments.
